September 29, World Heart Day is the world largest global awareness campaign on raising awareness on cardiovascular diseases. As part of Pfizer’s on-going contribution on interventions to control and reduce the risks of heart diseases in the country, Pfizer in partnership with Cardiac Health Initiative, has supported enlightenment activities on cardiovascular diseases and the modifiable risk factors associated with them.
The Medical Director, Pfizer, Dr. Kodjo Soroh, in a press statement to mark the event, said: “Our mission is to use innovative science to improve healthcare at every stage of life. Many risk factors associated with heart diseases can be prevented by addressing habits like the use of tobacco, unhealthy diet, lack of physical exercise and other modifiable CVD risk factors. We all need to take action for healthy hearts in our homes and communities”.
The programme, provided an informative platform for raising awareness on cardiovascular diseases and the importance of living healthy life styles to keep a healthy heart. This demonstrates Pfizer’s commitment to improve partnerships and strengthen advocacy platforms.
Nnenna Obibuaku, chief operating officer, Cardiac Health Initiative expatiated on the essence of the celebration, saying ”World Heart Day provides an opportunity to create an awareness of heart disease, the leading cause of death worldwide. In children, congenital heart disease is the most common type of birth defect worldwide, with an incidence of 3.5 per 1000 in Nigeria. Cardiac Health Initiative is focused on providing treatment for less privileged children and adults with heart disease. We organize public health campaigns, through which we provide free health screening within communities to check for heart disease”.
“We will continue to advocate for heart healthy environments and support the fight against non-communicable diseases through public health campaigns and public-private partnerships” – Ngozi Ushedo, media & public relations manager Pfizer.
